Business & M&A
InMode Receives Unsolicited $16.20-Per-Share Acquisition Proposal — What Device Owners Should Watch
A potential takeover bid signals consolidation pressure in the medical aesthetics device market.
Photo: Yan Krukau / Pexels
AI Inside MedSpa Intelligence · Jun 26, 2026
InMode Ltd. received an unsolicited acquisition proposal on June 17, 2026, valuing the company at $16.20 per share. The proposal came from a group that includes the company's CEO, signaling internal confidence in the company's value and strategic direction.
InMode is a major player in energy-based aesthetic devices (radiofrequency, microneedling RF, and other modalities). A change of control could reshape the competitive landscape for device-dependent practices. Owners using InMode platforms should monitor the situation for potential impacts on pricing, support, software updates, or product roadmaps.
$16.20 per share proposal from CEO-led group signals consolidation in device market.
Source: original report ↗
Frequently asked questions
What does InMode's $16.20 acquisition proposal mean for my practice?
A change of ownership could affect pricing, software updates, and customer support for InMode devices. Device-dependent practices should monitor the situation and consider diversifying their equipment portfolio to reduce reliance on a single manufacturer during this period of uncertainty.
Will InMode device pricing increase if the acquisition goes through?
There's no guarantee either way, but acquisitions often lead to pricing adjustments as new ownership restructures operations. It's prudent to lock in service agreements or purchase plans now if you're considering InMode equipment, and to ask your sales rep about pricing stability guarantees.
Who is making the acquisition offer for InMode?
The proposal came from a group that includes InMode's current CEO, signaling internal confidence in the company's value. The specific identity of other bidders or investors in the group has not been disclosed in the proposal announcement.
What InMode devices are most at risk from this acquisition?
InMode's radiofrequency, microneedling RF, and other energy-based aesthetic platforms are the core products that could be affected. Practices relying heavily on these modalities should ensure they have service contracts in place and stay informed about any changes to support or product roadmaps.
When will the InMode acquisition be finalized?
The proposal was received on June 17, 2026, but no timeline for completion has been announced. Acquisition negotiations typically take several months, so practices should expect uncertainty during this period and plan accordingly.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief every morning. The owners who read it never get blindsided.
Get the edge · $20/mo Join the owners who run ahead of the industry. Cancel anytime, one click.
